[Interdisciplinary Concepts of Paediatrics and Clinical Pharmacy to Optimise Anticonvulsant Treatment]

Thilo Bertsche1, Martina Patrizia Neininger1, Almuth Kaune1

  • 1Zentrum für Arzneimittelsicherheit und Klinische Pharmazie, Universität Leipzig.

Klinische Padiatrie
|December 20, 2017
PubMed

Insights

Effective epilepsy management in children requires multidisciplinary collaboration and optimized anticonvulsant administration. Educating healthcare professionals, families, and caregivers improves drug safety and patient quality of life.

Area of Science:

  • Pediatric Neurology
  • Clinical Pharmacy
  • Pharmacotherapy

Background:

  • Epilepsy diagnosis and treatment in children and adolescents necessitate diverse expertise.
  • Multidisciplinary healthcare professional cooperation is crucial for patient benefit.
  • Maintaining efficacy and minimizing risks in routine care are critical.

Purpose of the Study:

  • To emphasize the importance of drug prescription procedures, including anticonvulsant selection, combinations, and dosing.
  • To highlight the significance of appropriate drug administration for therapeutic success.
  • To outline strategies for improving drug administration involving various stakeholders.

Main Methods:

  • Review of drug prescription and administration protocols in pediatric epilepsy care.
  • Analysis of educational and training strategies for healthcare professionals, parents, children, adolescents, and caregivers.
  • Integration of pharmacists into the therapeutic team.

Main Results:

  • Optimized drug prescription and administration enhance therapeutic outcomes.
  • Targeted educational strategies improve adherence and reduce errors.
  • Involving pharmacists proactively prevents drug-related problems.

Conclusions:

  • Comprehensive strategies involving education and multidisciplinary collaboration improve pediatric epilepsy management.
  • Enhanced drug (therapy) safety leads to better patient participation and quality of life.
  • Pharmacist integration is key to optimizing anticonvulsant therapy and patient outcomes.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
284
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
256
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
323
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
335
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.1K
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
17